| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Rafael Padilla CEO | XSTU Exchange | BE0003874915 ISIN |
| BE Country | 3,828 Employees | 19 May 2025 Last Dividend | - Last Split | - IPO Date |
Fagron NV is a globally operating pharmaceutical compounding company, dedicated to offering personalized pharmaceutical care to a broad range of healthcare facilities and patients. The company categorizes its operations into three main segments: Essentials, Brands, and Compounding Services. It is actively engaged in the innovation of concepts, vehicles, and formulations to advance pharmaceutical compounding. Founded in 1990 and originally known as Arseus NV, the company underwent a name change to Fagron NV in January 2015 and has since established its base in Nazareth, Belgium. Fagron's mission is to bridge the gap between the unique needs of patients and the capabilities of the pharmaceutical industry by providing custom solutions. To support this mission, it also runs the Fagron Academy, which offers education and training to pharmacists and prescribers.